This is the authors' abstract. We don't add key points for this paper.
Kaposi’s sarcoma (KS) is the most common tumor associated with human immunodeficiency virus type 1 (HIV-1) infection, occurring in approximately 30% of HIV-1-infected homosexual men. The incidence of KS has increased in this risk group by more than 100 000-fold relative to the general population (1,2). However, KS is also increased in nonhomosexual HIV-infected males by about 10 000-fold (2,3). In the absence of HIV-1 infection, KS occurs very rarely in three distinct epidemiologic forms: 1) the classic form (disease seen in older men from certain ethnic groups) (4,5), 2) the endemic form (prevalent in some parts of equatorial Africa) (5,6), and 3) a form associated with renal transplant patients (7,8). It has not been clear whether all four forms of KS represent the same disease, or, like leukemias, lymphomas, and many other cancers (or immunodeficiencies), they have distinct causes and/or pathogenetic mechanisms and share only the end stage proliferation (or death) of the same cell types. A putative causative agent is human herpesvirus 8 (HHV8), also called KS-associated herpesvirus (9). HHV-8 nucleotide sequences are regularly found in all types of KS lesions (10–15), which has helped to define these tumor types as the same disorder. Aspects of KS that stimulate interest in this tumor are as follows: 1) the striking frequency of KS in HIV-1 infection, especially among homosexual men (1,16); 2) the mixed cellularity of the tumor that makes definition of the tumor cell ambiguous (17–19); 3) the question of whether the tumor is hyperplastic or neoplastic in nature (20–22); 4) the absence of KS in brain tissue; 5) the more frequent occurrence of KS in males than in females (1,2,16); 6) the relative resistance of KS to conventional therapies (which, of course, becomes worse when a patient is immunodeficient); 7) the different epidemiologic forms (noted above); 8) the absence of similar tumors in animals; and 9) the question of how HIV-1 infection dramatically increases the incidence of KS, despite the absence of HIV sequences in the KS tumor cells (18,23). (HIV-1 sequences are found only in cells infiltrating the tumor.) Until recently, there have been few reports that characterize these aspects of KS. This lack of research is due, at least in part, to the absence of a good animal model of spontaneous or induced KS and, in part, to difficulties in culturing KS tumor cells. In 1988, Gallo and colleagues (24,25) began to develop reproducible KS cell culture techniques to characterize the cultured cells (26–30), to study the role of HIV-1 in KS (31–35), to study and, when possible, to relate the in vitro cell culture data to clinical results (especially for data from KS biopsy specimens) (18), and to find biologic approaches to control tumor cell proliferation (36,37). Interpretations of the findings and hypotheses generated from this work are summarized below.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Reitz et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: